Study S001969

Impact of the Incretin System on Brain Insulin Sensitivity in Humans with Normal Weight, Overweight and Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06487832
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: SINGLE
Status: RECRUITING
Enrollment: 60
Start: 2024-07-01
Primary completion: 2027-07-31
Lead sponsor: University Hospital Tuebingen
Conditions: Normal Weight; Overweight and Obesity; Insulin Sensitivity; Insulin Resistance
Interventions: OTHER:Subcutaneous GLP1-RA; OTHER:Subcutaneous placebo
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Cerebral response after insulin compared to placebo nasal spray [24 hours after semaglutide or placebo administration]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.